ALFA Filings
Every announcement, straight from the exchange
Every Fischer Medical Ventures other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
Fischer Medical Ventures filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming no deviation in the utilization of preferential issue proceeds.